Unusual Options Activity Review: CV Therapeutics (CVTX)
CV Therapeutics (CVTX)
CV Therapeutics is rallying on news Astellas has made an offer to acquire the company for $16 per share. We wrote about unusual activity in CVTX on January 22 on WhatsTrading.com and also The Options Insider after an investor apparently opened a substantial bull call spread in CVTX last Wednesday. It was well played as both calls are now well in-the-money.
"
About Frederic Ruffy
Frederic Ruffy is a Freelance Writer and Options Trading Strategist. In addition to writing market commentary and trading-related books and articles, Fred has also worked as an instructor, educating investors on advanced topics like measuring volatility, the benefits of sector rotation and the risks and potential profits from trading around earnings. His market observations are mentioned frequently in the financial press and he currently trades stocks, futures, and options in Salt Lake City, Utah.
View Frederic Ruffy's post archive >